Edelweiss Recently Listed IPO Fund Regular Plan Growth
Medium
Risk
Equity
Other
+
14.91
%
14.91
%
3Y annualised
+
0.88
%
0.88
%
1D
1M
6M
1Y
3Y
All
Fund size
943
NAV:
Mar 7, 2024
23.0261
Sector
Tech
Type
Equity
Launched
Feb 2018
Min Investment
100
Expense Ratio
2
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Global Health Ltd
4.77
%
KFin Technologies Ltd
4.43
%
Mankind Pharma Ltd
3.67
%
JSW Infrastructure Ltd
3.4
%
Concord Biotech Ltd
3.24
%
Bikaji Foods International Ltd
3.04
%
Rainbow Childrens Medicare Ltd
2.68
%
Five-Star Business Finance Ltd
2.66
%
Fusion Micro Finance Ltd
2.65
%
Syrma SGS Technology Ltd
2.61
%
Expense ratio, exit load and tax
Expense Ratio:
2
%
Inclusive of GST
Exit load
Exit load of 2.0% if redeemed within 180.0 Days, 0.0 % if redeemed after 180.0 Days.
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
Edelweiss Recently Listed IPO Fund Regular Plan Growth
More details
Investment objective
The investment objective of the Scheme is to seek to provide capital appreciation by investing in equity and equity related securities of recently listed 100 companies or upcoming Initial Public Offers (IPOs).
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
